| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 28 |
| 1 | METHOTREXATE | 24 |
| 2 | PACLITAXEL | 23 |
| 3 | ADALIMUMAB | 20 |
| 4 | CYCLOPHOSPHAMIDE | 19 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 19 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 19 |
| 7 | TRASTUZUMAB | 18 |
| 8 | PACLITAXEL (AIBUMIN-BOUND) | 17 |
| 9 | PERTUZUMAB | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 1 | 0.0204 |
| 1 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 2 | ORITAVANCIN DIPHOSPHATE | 2 | 0.0067 |
| 3 | ACAMPROSATE CALCIUM | 1 | 0.0030 |
| 4 | MOSUNETUZUMAB | 2 | 0.0018 |
| 5 | IBANDRONATE SODIUM | 5 | 0.0016 |
| 6 | TREOSULFAN | 4 | 0.0014 |
| 7 | PORACTANT ALFA | 1 | 0.0014 |
| 8 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | 2 | 0.0014 |
| 9 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE | 2 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 41 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 3 | Microtubule Inhibitor [EPC] | 25 |
| 4 | Kinase Inhibitor [EPC] | 24 |
| 5 | Benzodiazepine [EPC] | 22 |
| 6 | Alkylating Drug [EPC] | 19 |
| 7 | Platinum-based Drug [EPC] | 19 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 18 |
| 9 | Opioid Agonist [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 1 | 0.0009 |
| 1 | Monobactam Antibacterial [EPC] | 2 | 0.0007 |
| 2 | Anthelmintic [EPC] | 2 | 0.0007 |
| 3 | Lipopeptide Antibacterial [EPC] | 6 | 0.0006 |
| 4 | Actinomycin [EPC] | 1 | 0.0005 |
| 5 | CD30-directed Immunoconjugate [EPC] | 3 | 0.0003 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 18 | 0.0002 |
| 7 | Penem Antibacterial [EPC] | 7 | 0.0002 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 9 | Estrogen Receptor Antagonist [EPC] | 7 | 0.0002 |